Arrowhead Pharmaceuticals
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Arrowhead Pharmaceuticals
RECRUITINGPhase 3NCT06880770
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
This study will evaluate the efficacy and safety of plozasiran in approximately 288 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 28820 locations
Severe Hypertriglyceridemia
RECRUITINGPhase 3NCT06822790
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
This is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (SHTG). Each participant must have completed all required...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 86920 locations
Hypertriglyceridemia
RECRUITINGPhase 1 / Phase 2NCT07223658
Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 781 location
Hyperlipidemia; Mixed